Is echocardiography reliable for monitoring the adverse cardiac effects of chemotherapy?

Journal of the American College of Cardiology

Volumn 61, Issue 1, 2013, Pages 85-87

  Mor Avi, Victor ^a   Lang, Roberto M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

3D echocardiography; chemotherapy; interobserver test re test variability; interobserver variability; longitudinal variability

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER PATIENT; CARDIOTOXICITY; CORRELATION COEFFICIENT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HUMAN; INTERMETHOD COMPARISON; MEASUREMENT ERROR; NOTE; PATIENT MONITORING; PRIORITY JOURNAL; SIDE EFFECT; TEST RETEST RELIABILITY; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 84872043378     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.10.006     Document Type: Editorial

References (12)

1. L. Elbl, H. Hrstkova, I. Tomaskova, B. Blazek, J. Michalek Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients Eur J Pediatr 164 2005 678 684
2. S. Tassan-Mangina, D. Codorean, M. Metivier Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study Eur J Echocardiogr 7 2006 141 146
3. M. Kantar, E. Levent, N. Cetingul Plasma natriuretic peptides levels and echocardiographic findings in late subclinical anthracycline toxicity Pediatr Hematol Oncol 25 2008 723 733
4. H. Sawaya, I.A. Sebag, J.C. Plana Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes and trastuzumab Circ Cardiovasc Imaging 5 2012 596 603
5. S.A. Lange, B. Ebner, A. Wess Echocardiography signs of early cardiac impairment in patients with breast cancer and trastuzumab therapy Clin Res Cardiol 101 2012 415 426
6. P. Thavendiranathan, A.D. Grant, T. Negishi, J.C. Plana, Z.B. Popović, T.H. Marwick Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy J Am Coll Cardiol 61 2013 77 84
7. J.L. Hare, J.K. Brown, R. Leano Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab Am Heart J 158 2009 294 301
8. E. Ho, A. Brown, P. Barrett Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study Heart 96 2010 701 707
9. H.R. Tsai, O. Gjesdal, T. Wethal Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy Am J Cardiol 107 2011 472 477
10. H. Sawaya, J.C. Plana, M. Scherrer-Crosbie Newest echocardiographic techniques for the detection of cardiotoxicity and heart failure during chemotherapy Heart Fail Clin 7 2011 313 321
11. M. Martin, F.J. Esteva, E. Alba Minimizing cardiotoxicity while optimizing treatment efficacy with trastuzumab: review and expert recommendations Oncologist 14 2009 1 11
12. R.M. Lang, V. Mor-Avi, J.M. Dent, C.M. Kramer Three-dimensional echocardiography: is it ready for everyday clinical use? J Am Coll Cardiol Img 2 2009 114 117